Based Screening News Today

Existing research shows certain types of migraines can increase the risk of stroke, and there is growing evidence that they may also lead to other types of cardiovascular disease (CVD).

Activation of the NRF2 transcription factor shows promise as a potential treatment approach for non-alcoholic fatty liver disease (NAFLD), a condition associated with oxidative stress and liver damage. By screening FDA-approved drugs, researchers identified six compounds that enhanced NRF2 activity and demonstrated protective effects against oxidative stress and lipid accumulation.

Investegate announcements from Xtrackers, Important Notice to Shareholders of Xtrackers DAX Income UCITS ETF

COVID-19 Saliva-based Screening Market is likely to register double digit 2.4% CAGR during 2026 – 2031